Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

Abstract Background Anti-TNF treatment may be useful for the treatment of patients with refractory juvenile dermatomyositis (JDM). The aim of this study was to describe the use of infliximab and adalimumab therapy in juvenile dermatomyositis as an adjunctive treatment. Methods Sixty children recruit...

Full description

Bibliographic Details
Main Authors: Raquel Campanilho-Marques, Claire T. Deakin, Stefania Simou, Charalampia Papadopoulou, Lucy R. Wedderburn, Clarissa A. Pilkington, for the Juvenile Dermatomyositis Research Group (JDRG)
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Arthritis Research & Therapy
Subjects:
Infliximab
Adalimumab
Juvenile dermatomyositis
Biologic therapy
P rheumatology
Online Access:http://link.springer.com/article/10.1186/s13075-020-02164-5

Internet

http://link.springer.com/article/10.1186/s13075-020-02164-5

Similar Items